Next-Generation Sequencing For Adventitious Virus Detection Helps Speed Response To COVID-19
Executive Summary
It's another case where the pandemic spurs adoption of ways to speed the manufacture of vaccines and biologics that have been in development for years.
You may also be interested in...
ICH Revises Viral Safety Guideline For New Types Of Products, Processes And Methods
Draft rewrite issued for comment updates 20-year-old Q5A document with advice around new developments like the advent of viral vectors, continuous manufacturing and next-generation sequencing.
WHO Proposes Reference Standard For Adventitious Virus Detection
Emerging global standard could speed testing of biologics and gene therapies for stray viral particles, while sparing laboratory animals.
FDA's CMC Guidance For Investigational Gene Therapies Reflects Broader CMC Evolution
New draft document addresses issues with applying quality-by-design to gene therapies, accommodating the Common Technical Document format, as well as drug substance, cell bank and contract manufacturing issues. US FDA's Denise Gavin offers insights on agency thinking at gene therapy conference.